By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Beta-blocker > Metoprolol

Metoprolol

GMJ
Last updated: 02/06/2026 14:31
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|638 words

Metoprolol Drug Profile

What is Metoprolol?

Metoprolol is a prescription medication belonging to a class of drugs called beta-blockers, specifically beta-1 selective blockers. It is primarily used to treat high blood pressure, chest pain (angina), and heart failure, and to improve survival after a heart attack. This medication works by blocking certain stress hormones from affecting the heart and blood vessels.

Uses

Metoprolol has several FDA-approved medical uses:

  • High blood pressure (hypertension): Helps lower blood pressure by reducing the heart’s workload and relaxing blood vessels
  • Angina pectoris: Reduces chest pain episodes by decreasing the heart’s oxygen demand during physical activity or stress
  • Heart failure: Improves heart function and reduces hospitalizations in patients with chronic heart failure when used alongside other heart failure medications
  • Post-heart attack treatment: Reduces the risk of death and subsequent heart attacks when started within days of a heart attack
  • Abnormal heart rhythms: Sometimes prescribed off-label to help control certain types of irregular heartbeats

How it works

Metoprolol works by selectively blocking beta-1 receptors in the heart, which are normally activated by stress hormones like adrenaline and noradrenaline. By blocking these receptors, metoprolol reduces heart rate, decreases the force of heart contractions, and lowers blood pressure. This reduces the heart’s workload and oxygen requirements, making it particularly beneficial for people with heart conditions.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Fatigue and weakness
  • Dizziness or lightheadedness
  • Slow heart rate (bradycardia)
  • Cold hands and feet
  • Digestive issues (nausea, diarrhea, constipation)
  • Sleep disturbances or vivid dreams
  • Shortness of breath during exercise
  • Depression or mood changes

Serious side effects requiring immediate medical attention:

  • Severe breathing difficulties or wheezing
  • Signs of heart failure (swelling in legs/ankles, sudden weight gain)
  • Extremely slow or irregular heartbeat
  • Severe dizziness or fainting
  • Chest pain or worsening angina symptoms

Warnings and precautions

  • Asthma and COPD: Should be used with extreme caution in patients with respiratory conditions, as it may worsen breathing problems despite being beta-1 selective
  • Diabetes: May mask symptoms of low blood sugar and can affect blood glucose control, requiring closer monitoring
  • Sudden discontinuation: Should never be stopped abruptly as this can cause dangerous rebound effects including heart attack, especially in patients with coronary artery disease
  • Pregnancy: Classified as pregnancy category C; should only be used when benefits outweigh potential risks to the fetus
  • Kidney and liver function: Dosage adjustments may be necessary in patients with severe liver impairment, though kidney problems typically don’t require dose changes

Interactions

  • Calcium channel blockers (verapamil, diltiazem): Can cause dangerously slow heart rate and low blood pressure when combined
  • Digoxin: Metoprolol can increase digoxin levels, potentially leading to toxicity
  • Insulin and diabetes medications: May enhance blood sugar-lowering effects and mask hypoglycemia symptoms
  • NSAIDs (ibuprofen, naproxen): Can reduce metoprolol’s blood pressure-lowering effectiveness
  • Antiarrhythmic drugs (amiodarone, propafenone): May increase risk of heart rhythm problems
  • MAO inhibitors: Can cause severe interactions affecting blood pressure and heart rate
  • Alcohol: May enhance the blood pressure-lowering effects and increase drowsiness
  • Epinephrine (adrenaline): Beta-blockers can alter the body’s response to emergency epinephrine treatment

Check interactions with the GMJ Interaction Checker

Dosage

Metoprolol dosages vary significantly based on the condition being treated and whether the immediate-release or extended-release formulation is used. For high blood pressure, typical starting doses range from 25-100 mg twice daily for immediate-release tablets, or 25-100 mg once daily for extended-release formulations. Heart failure treatment usually begins with much lower doses (12.5-25 mg twice daily) and is gradually increased. Post-heart attack treatment may involve 25-50 mg twice daily, started within days of the event. All dosing should be individualized and carefully monitored by a healthcare provider, who will adjust the dose based on response and tolerance.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Metoprolol." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/metoprolol-2/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Child Mortality Progress Stalls: 60 Countries Risk Missing 2030 UN Targets

New BMJ analysis reveals 60 countries unlikely to meet UN child survival…

Scientists Discover Master Clock That Controls Biological Growth and Development

Scientists have identified a genetic master clock that controls biological development timing.…

Brain immune cells reveal why some people resist dementia despite tau tangles

New Nature Medicine research reveals how brain immune cells determine whether people…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Propranolol

By
Prof. Giorgi Pkhakadze
02/06/2026

Carvedilol

By
Prof. Giorgi Pkhakadze
02/06/2026

Sotalol

By
Prof. Giorgi Pkhakadze
02/06/2026

Labetalol

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up